Richard Frame, MD
Hematology & Oncology Physician in Salt Lake City, Utah.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Richard Frame, MD reported a CMS MIPS final score of 73.9/100 - below the 83.5 national average - and filed 78 Medicare Part D claims in 2024.
- 73.9/100
- MIPS score · -10 vs avg
- 78
- Part D claims, 2024
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Richard Frame, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1073563516), first enumerated 05/12/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 78 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 73.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$106.73 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Frame with other Hematology & Oncology Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Utah
- Dr. Candice Baldeo, MD Salt Lake City, UT
- Dr. Katharine Barford, MD Riverton, UT
- Dr. Anna Beck, MD Salt Lake City, UT
- Dr. Ali Ben-Jacob, MD Logan, UT
- Dr. Wendy Breyer, MD Murray, UT
- Dr. Scott Browning, MD Salt Lake City, UT
Other specialties in Salt Lake City: Case Manager/Care Coordinator (1,971) · Student in an Organized Health Care Education/Training Program (1,718) · Community Health Worker (1,661) · Behavior Technician (1,240)
CMS NPPES provider registry desk
NPI 1073563516 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-TRACE · BOOK-THIN · PHOTO-FINISH
- NPI-10 1073563516
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- MIPS-BELOW 73.9/100
- RX-TRACE 78
- BOOK-THIN 80 in Utah
- PHOTO-FINISH Neil Schacht, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Abirami Sivapira…
Abirami Sivapiragasam, MD
73.8 MIPS pts
- Alex Metzger, M.…
Alex Metzger, M.D.
73.8 MIPS pts
- Frame · this pro…
Frame · this provider
73.9 MIPS pts
- Neil Schacht, MD…
Neil Schacht, MD
73.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Richard Frame, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
74 ≥ 11th percentile 11% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Richard Frame, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Richard Frame, MD writes more Part D claims than 7% of them and scores higher on MIPS quality than 11% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Richard Frame, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Richard Frame, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Richard Frame, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Utah
How Hematology & Oncology Physician compares to other specialties among Utah providers
Hematology & Oncology Physician ranks #83 among Utah's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Utah provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Richard Frame, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 73.9/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
73.9/100 MIPS final score - 9.6 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 61. Cost dim: 50.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1073563516 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Richard Frame, MD's current license status, disciplinary history, and board certifications with the Utah Division of Professional Licensing in Utah before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1073563516 is the unique 10-digit identifier CMS uses to link Frame across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Richard Frame, MD. Source: openpaymentsdata.cms.gov.
Total received
$107
Largest payer
Daiichi Sankyo Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 86% generic, on 78 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 127.667
- Total Day Supply
- 3,233
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $108K
- Generic Drug Cost
- $980
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 2.22
- Gender Split
- 65% female / 35% male
Hematology & Oncology Physician Overview
How Richard Frame, MD fits within the Hematology & Oncology Physician landscape nationally.
Richard Frame, MD's 78 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Frame, both outside Utah so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (73.9 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Utah
Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as Frame.
One of 80 Hematology & Oncology Physician providers enrolled in Utah, 11 are shown on this page.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Richard Frame, MD's specialty? ▼
How much does Richard Frame, MD prescribe under Medicare Part D? ▼
What is Richard Frame, MD's Medicare quality score? ▼
Where is Richard Frame, MD located? ▼
What is Richard Frame, MD's NPI number? ▼
Does Richard Frame, MD prescribe more brand-name or generic drugs? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
Does Richard Frame, MD accept Medicare? ▼
How can I verify Richard Frame, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.